A carregar...
Biosimilar switching – current state of knowledge
Evidence from over 10 years of clinical experience demonstrates that biosimilar medicines approved in the European Union can be used for all their registered indications as safely as their originators and with no negative impact on therapeutic efficacy. The debate on the use of biosimilars in rheuma...
Na minha lista:
| Publicado no: | Reumatologia |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6142020/ https://ncbi.nlm.nih.gov/pubmed/30237628 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/reum.2018.77975 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|